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ABSTRACT
PURPOSE: To compare gene expression of the chemokines RANTES and eotaxin-2, its receptor, CCR-3, adhesion molecule ICAM-1 
and its receptor LFA-1 in eosinophilic polyps and in control normal nasal mucosa. 
METHODS: Gene expression was quantified by Real Time PCR in polyps (n=35) and in healthy nasal mucosa (n=15). 
RESULTS: Eosinophilic polyps showed a higher expression of eotaxin-2 and RANTES, but not of CCR-3, ICAM-1 or LFA-1 compared 
to control nasal mucosa. 
CONCLUSION: Eosinophilic polyps present greater expression of eotaxin-2 and RANTES, but not of CCR-3, ICAM-1 or LFA-1 
compared to control nasal mucosa.
Key words: Nasal Polyps. Chemokines. Intercellular Adhesion Molecule-1. Sinusitis.
RESUMO
OBJETIVO: Comparar a expressão gênica das quimiocinas RANTES e eotaxina-2, do seu receptor CCR-3, da molécula de adesão 
ICAM-1 e do seu receptor LFA-1 entre pólipos nasais eosinofílicos (PE) (n=35) e mucosa nasal controle (n=15). 
MÉTODOS: Quantificou-se a expressão gênica dos mediadores citados pela técnica de PCR em tempo real em PEs e em mucosas de 
concha média de pacientes sem doenças nasais ou alteração endoscópica. 
RESULTADOS: Pólipos eosinofílicos apresentam maior expressão de eotaxina-2 e RANTES, mas não de CCR-3, ICAM-1 e LFA-1, 
quando comparados as mucosas nasais controles. 
CONCLUSÃO: Pólipos eosinofícios apresentaram maior expressão de eotaxin-2 and RANTES, mas não de CCR-3, ICAM-1 ou LFA-
1,comparada à mucosa nasal controle.
Descritores: Pólipos Nasais. Quimiocinas. Molécula 1 de Adesão Intercelular. Sinusite 
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Introduction
Nasosinusal polyposis (NSP) is a disease with a variety 
of clinical manifestations which is frequently associated with 
other diseases such as asthma, cystic fibrosis, primary ciliary 
dyskinesia, and hypersensitivity to aspirin. It is considered a 
chronic inflammatory disease associated with rhinosinusitis 
(CRS with NSP) characterized by intense eosinophilia and tissue 
remodeling consisting of epithelial proliferation, hyperplasia 
of secretory cells, pseudocyst formation, thinning of basement 
membranes, localized fibrosis and edema1,2.
Several hypothesis have been raised to elucidate the 
disease’s mechanisms of action, but its etiopathogeny is not yet 
completely understood.
Some factors may influence the severity of the clinical 
symptoms, one of the main factors being related to predisposing 
genetic components. These may affect the expression of 
inflammatory cytokines and chemokines, with consequences 
for the severity of the inflammatory process2,3. This “genetic 
predisposition” may be added to external factors such as allergy, 
bacterial infection (especially in the presence of the formation of 
biofilms and/or superantigens) or even fungal infection to form the 
phenogenotype of CRS with NSP4-7.
Some proinflammatory factors have been proven to be 
involved in the process of formation of CRS with NSP, such as 
interleukins 4, 5, 6 and 8, transforming growth factor (TGF), 
some chemokines (eotaxins and RANTES), metalloproteinases 
(MMPs), and adhesion molecules (VCAM-1)1-3.
The chemokines RANTES (Regulated on Activation 
Normal T Expressed and Secreted) and eotaxin-2 are important 
recruiters and activators of eosinophils and have been postulated 
to be responsible for eosinophilia in the tissue stroma of the 
polyp8-18. About this matter, the interaction of chemokines with 
their receptors in CRS with NSP is important, with CCR-5 and 
CCR-3 being the receptors more extensively studied19. Both are 
present in the normal nasal mucosa and both have been widely 
studied in allergy, where obvious tissue eosinophilia has also been 
observed. They are expressed both in basophils and in eosinophils. 
However, the quantification of their expression and consequent 
correlation with chemokine expression have not been properly 
studied in CRS with NSP.
Another class of inflammatory mediators whose role in 
CRS with NSP needs to be better studied is the adhesion molecules 
(such as VCAM-1 and ICAM-1) and their receptors (such as LFA-
1). The adhesion molecule ICAM-1 plays an important role in 
the intercellular inflammatory cascade and is responsible for the 
migration of inflammatory cells to the affected tissue. Its role in 
CRS with NSP has not been clarified despite its high levels of 
expression20.
Thus, the objective of the present study was to investigate 
the expressions of the chemokines RANTES and eotaxin-2, of 
their receptor CCR-3, of the adhesion molecule ICAM-1 and 
its receptor LFA-1 in CRS with NSP and compare them to the 
expression of control nasal mucosa.
Methods
Thirty-five patients with CRS and NSP were selected 
and submitted to endoscopic surgery at the Rhinology unit of a 
university hospital after failure to obtain beneficial effects with an 
optimized clinical treatment. The diagnosis was confirmed in all 
patients by nasofibroscopy and computed tomography according 
to the Brazilian directives for rhinosinusitis21. Nasal polyp samples 
were obtained during the surgical procedure and immediately 
stored in Trizol® at -70oC. Samples of the meatal surface of the 
middle turbinate were obtained from 15 patients submitted to 
aesthetic rhinoplasty who had no nasal complaints, no history of 
nasal diseases, or abnormal findings in the physical examination 
of the nasal cavity. 
The study was approved by the Ethics Committee of 
the hospital (protocol no. 8897/09) and all patients gave written 
informed consent to participate. Patients younger than 13 years, 
with unilateral nasal disease, cystic fibrosis, inverted papilloma or 
ciliary dyskinesia were excluded from the study.
mRNA was extracted from all samples by the Trizol® 
technique (Invitrogen) according to manufacturer specifications. 
The extracted mRNA was quantified with a ThermoScientific® 
spectrophotometer model Nanodrop 1000. After confirmation 
of its integrity, cDNA was determined in each sample using the 
Improm-II Promega kit according to manufacturer instructions. 
For real-time PCR, the cDNAs of the samples were 
added to the primers obtained from Invitrogen of the genes 
RANTES, eotaxin-2, CCR-3, ICAM-1 and LFA-1, in addition to 
the housekeeping gene beta-actin. The reaction was performed 
using the SYBR Green® marker in the ABI 7000 Biosystems® 
Detection System (SDS ABI 7000),and quantification was carried 
out by delta-delta CT analysis. 
Data were analyzed statistically and graphs were 
constructed using the GraphPad-Prism 5.0 software. All reactions 
were analyzed and compared by the nonparametric Mann-Whitney 
test, with the level of significance set at p <0.05.
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Results
Comparison of RANTES expression between nasal 
polyps and control nasal mucosa samples revealed a significantly 
higher expression of the genes RANTES (4.07±1.18 for polyps vs. 
0.75±0.69 for control mucosa, p<0.05) and eotaxin-2 (17.97±8.13 
for polyps vs. 2.03±1.32 for control mucosa, p<0.05) (Figures 1 
and 2).
FIGURE 1 - Comparison of the expression of RANTES in nasal polyps 
vs. controls.
FIGURE 2 - Comparison of the expression of eotaxin-2 in nasal polyps 
vs. controls.
In contrast, the expression of the other inflammatory 
mediators studied did not differ significantly between nasal polyps 
and normal control mucosa (CCR-3: 0.47±18.09 for polyps vs. 
1.05±0.57 for control mucosa; ICAM-1: 1.00±0.26 for polyps vs. 
0.79±1.21 for control mucosa; LFA-1: 3.43±1.06 for polyps vs. 
3.29±0.72 for control mucosa, with a non significant p value for 
all of them).
Discussion
Cytokines, chemokines, adhesion molecules, 
metalloproteinases and inducers of cell apoptosis are becoming 
increasingly important targets in the area of rhinosinusology1-3,8-24 
for a better understanding of the mechanism of onset and 
maintenance of the inflammatory cascade in CRS with NSP and the 
consequent determination of therapeutic targets for the inhibition 
of these inflammatory mediators.
RANTES is an important chemokine for the recruitment 
and activation of eosinophils in different types of tissues and its 
relation to CRS with NSP has been studied in different manners. 
Using semi-quantitative RT-PCR, Lane et al.17detected higher 
expression of RANTES in patients with chronic rhinosinusitis 
(with and without polyposis) compared to patients with a normal 
mucosa. Marcella et al.16 compared nasosinusal polyps of allergic 
and non-allergic patients to normal mucosa by semi-quantitative 
RT-PCR and detected higher expression of RANTES in both polyp 
groups than in normal nasal mucosa. Using the same methodology, 
Meyer et al.12 observed higher expression of RANTES in 
eosinophilic than non-eosinophilic polyps. These studies 
demonstrated the importance of RANTES in the eosinophilia of 
nasal polyps regardless of their allergic or non-allergic origin.
Eotaxin-2 is another chemokine related to eosinophilia 
which has been strongly related to CRS with NSP, and associated 
with RANTES on many occasions. In a study with a methodology 
similar to that used in the present investigation, Valera et al.24 
evaluated the expression of various inflammatory mediators, 
including eotaxin-2. Comparing polyp and control nasal mucosa, 
they noted higher expression of eotaxin-2 in the polyps. Shin 
et al.13studied the expression of eotaxin-2 and RANTES in normal 
tissues, eosinophilic and non-eosinophilic polyps and observed 
that the eosinophilic polyps expressed more eotaxin than the other 
two groups. However, these authors did not observe a difference in 
the expression of RANTES, in contrast to previous literature data 
and to the data obtained in the present study. Using ELISA, Olze 
et al.14observed a higher concentration of proteins of eotaxins-1, 2 
and 3 in eosinophilic polyps than in normal nasal concha mucosa.
Po
lyp
s
Co
ntr
ols
0
5
10
15
20
expression related to b  actin
Po
lyp
s
Co
ntr
ols
0
20
40
60
expression related to b  actin
Cavallari FE et al.
648 - Acta Cirúrgica Brasileira - Vol. 27 (9) 2012
The CCR-3 receptor is related to both RANTES and 
eotaxin-2, but with greater specificity for the latter. It is widely 
related to the type Th2 (eosinophilic) inflammatory response. 
However, its study in CRS with NSP is not so extensive regarding 
the chemokines. In one of the rare relevant studies involving 
CCR-3 and CRS with NSP, Kim et al.19 showed higher CCR-3 
expression in eosinophilic than non-eosinophilic polyps using 
immunohistochemistry. There are no reports thus far of studies 
comparing the expression of CCR-3 between samples of CRS with 
NSP and control nasal mucosa.
The adhesion molecule ICAM-1 and its receptor LFA-1 
are highly related to the proinflammatory infiltrate although they 
are not specific for the lymphocyte response mainly of the Th2 
type. We did not observe a difference in the expression of these 
two genes between polyps and controls, but this finding may be 
explained exactly by the type of lymphocyte response to which 
these mediators are related. Among studies of adhesion molecules 
in NSP, Olejniczak et al.25 compared the protein expression of 
ICAM-1 between allergic and non-allergic patients with NSP 
by immunohistochemistry and observed higher expression in 
the group of allergic patients. In a report previously cited in the 
present paper because it also involved the study of eotaxin-2, 
Valera et al.24 compared nasal polyp and normal nasal mucosa 
regarding the expression of ICAM-1 and found no significant 
difference between groups. Corsi et al.20 evaluated by microarray 
the expression of adhesion molecules in individuals with CRS with 
NSP compared to individuals without nasal disease and detected 
increased expression of selectins and VCAM-1, but not of ICAM-
1, in nasal polyps. 
The present study demonstrates the close relation 
between eosinophilic polyps and the expression of chemokines 
with a pattern of Th2 inflammation, confirming the effect of the 
inflammatory process in this direction, with a clear and continuous 
induction of eosinophilia in tissue. The possible determination of 
medications that would inhibit the expression of these chemokines 
may be of help in reducing the inflammatory process present in 
CRS with NSP.
Conclusion
Eosinophilic polyps present greater expression of 
eotaxin-2 and RANTES, but not of CCR-3, ICAM-1 or LFA-1 
compared to control nasal mucosa.
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